News - Alkermes
BYDUREON(TM), First and Only Once-Weekly Type 2 Diabetes Treatment, Now Available in U.S. Pharmacies
2012-02-13 07:00:00
SAN DIEGO and DUBLIN, Feb. 13, 2012 /PRNewswire/ -- Amylin Pharmaceuticals, Inc.
2012-01-27 14:39:00
SAN DIEGO and DUBLIN, Jan. 27, 2012 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Alkermes plc (Nasdaq: ALKS) today announced that the U.S.
2011-11-16 08:30:00
Alkermes plc (Nasdaq: ALKS), Elan Corporation (NYSE: ELN), Sprint (NYSE: S), AT&T (NYSE: T) and Verizon
2011-11-09 10:25:36
Alkermes plc (NASDAQ: ALKS) today presented positive results from a long-term study of VIVITROL® (naltrexone for extended-release injectable suspension) at the 24th Annual U.S. Psychiatric and Mental Health Congress in Las Vegas, NV.
2011-09-12 06:00:00
LISBON, Portugal, Sept. 12, 2011 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc.